Clinical Trial Update: Trail Evaluating Particle Therapy With or Without Apatinib for H&N Adenoid Cystic Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating particle therapy with or without apatinib for head and neck adenoid cystic carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenoid Cystic Carcinoma

Drugs mentioned

• Apatinib (apatinib)
• particle therapy

Snippet

Sponsor: Shanghai Proton and Heavy Ion Center | Conditions: Adenoid Cystic Carcinoma | Phase 2 | Status: UNKNOWN